OP62 Polymorphisms in AKT1 and EGFR as possible new biomarkers of clinical outcome and toxicity in non-small-cell lung cancer patients treated with gefitinib

2009 ◽  
Vol 7 (4) ◽  
pp. 9
Author(s):  
E. Giovannetti ◽  
P. Zucali ◽  
C. Tibaldi ◽  
E. Smit ◽  
A. Falcone ◽  
...  



Tumor Biology ◽  
2012 ◽  
Vol 34 (2) ◽  
pp. 941-946 ◽  
Author(s):  
Long-Xiao Wei ◽  
Run-Suo Zhou ◽  
Hai-Feng Xu ◽  
Jun-Yan Wang ◽  
Meng-Hui Yuan


2017 ◽  
Vol 12 (11) ◽  
pp. S2429-S2430
Author(s):  
W. Park ◽  
D. Kwon ◽  
D. Saravia ◽  
A. Desai ◽  
J. Warsch ◽  
...  




Lung Cancer ◽  
2009 ◽  
Vol 66 (1) ◽  
pp. 114-119 ◽  
Author(s):  
Fei Ma ◽  
Tong Sun ◽  
Yuankai Shi ◽  
Dianke Yu ◽  
Wen Tan ◽  
...  


BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Mary Jo Fidler ◽  
Cristina L. Fhied ◽  
Joanna Roder ◽  
Sanjib Basu ◽  
Selina Sayidine ◽  
...  


PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0129232 ◽  
Author(s):  
Xueying Zhao ◽  
Shiming Wang ◽  
Junjie Wu ◽  
Xiaoying Li ◽  
Xun Wang ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document